DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Ottawa Marriott Hotel

2018 年 10 月 30 日 7:00 上午 - 2018 年 10 月 31 日 3:00 下午

100 Kent Street , Ottawa, ON K1P5R7 , CANADA

DIA Annual Canadian Meeting

Transformation with Collaboration

概览

Short Courses: October 29
Meeting: October 30-31


The DIA Annual Canadian Meeting will deliver a comprehensive overview of the current bio-pharma and device landscape in Canada, while sharing insights into Canada’s broader role in global healthcare product development. From policy updates and priorities shared directly from Health Canada, to sessions on international work sharing and partnerships to key regulatory and clinical considerations for drugs and devices, you will have the exclusive opportunity to address the current issues and opportunities in Canada and across the globe.

Bringing together key stakeholders from the drug (innovator and generic/biosimilar)/, device and Patient Self Care industries, regulatory agencies, and academia, this meeting will discuss/analyze the relevant challenges and opportunities for professionals working in the field in Canada.

This year’s meeting will feature preconference short courses, plenary sessions, multi-track breakout sessions and multiple networking opportunities.

Featured

Want to learn more about DIA Annual Canadian Meeting? You've come to the right site!

Highlights & Features

Continuing Education

谁应该参加?

Professionals in pharmaceutical and device industries, regulatory agencies, and academia involved in:

  • clinical data management/eClinical
  • comparative effectiveness/health technology assessment
  • clinical safety/pharmacovigilance
  • clinical research
  • document management/eSubmissions
  • medical communications
  • outsourcing
  • project management
  • public policy/law/corporate compliance
  • quality assurance control
  • regulatory affairs
  • research and development
  • statistics

学习目标

At the conclusion of this meeting,, participants should be able to:

  • Describe the current and evolving regulatory environment in Canada
  • Summarize methods and approaches in various aspects of clinical trials, patient engagement, and market access
  • Discuss more in-depth, approaches on international harmonization, worksharing, and adoption of guidelines
  • Review the various levels of transparency and post-market activities that are underway

Short Course or Primer

To keep you at the forefront.

2018 年 10 月 29 日

Short Course 1:

Policy and Regulatory Development at the Health Products and Food Branch (HPFB)

2018 年 10 月 29 日

Short Course 2:

Regulatory Renewal

项目委员会

  • Karen  Feltmate
    Karen Feltmate President
    Redstone Health Group, Inc., Canada
  • Marc  Poitras, PhD, MBA
    Marc Poitras, PhD, MBA Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
    Health Canada, Canada
  • Marilena  Bassi, MA
    Marilena Bassi, MA Senior Executive Director, Therapeutic Products Directorate
    Health Canada, Canada
  • Lisa  Chartrand
    Lisa Chartrand Director, Regulatory Strategy and Policy
    Hoffmann-La Roche Limited, Canada
  • Loretta  Del Bosco
    Loretta Del Bosco Director, Regulatory Affairs Quality Assurance Operations
    AbbVie Corporation, Canada
  • Fiona M Frappier, PhD
    Fiona M Frappier, PhD Senior Policy Analyst
    Health Canada, Canada
  • Lorella  Garofalo, PhD
    Lorella Garofalo, PhD Head of Regulatory Sciences
    Pfizer Canada ULC, Canada
  • Melissa  Hunt, MSc
    Melissa Hunt, MSc Director
    Health Canada, Canada
  • Rania  Mouchantaf, PhD
    Rania Mouchantaf, PhD A/Executive Director, Marketed Pharmaceuticals Bureau, MHPD
    Health Canada, Canada
  • Lissa  Murseli
    Lissa Murseli Manager
    Health Canada, Canada
  • Polina  Ostrovsky, MPH
    Polina Ostrovsky, MPH Policy Analyst
    Health Canada, Canada
  • Kristin  Willemsen, MS
    Kristin Willemsen, MS Vice President, Scientific & Regulatory Affairs
    Food, Health & Consumer Products of Canada, Canada

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。